Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua: a Randomized, Double Blind,Placebo Controlled, Phase III Trial
Conditions
Interventions
AIT drops
placebo drops
Locations
13
China
Beijing Shijitan Hospital
Beijing, China
Beijing Tongren Hospital
Beijing, China
Peking University People's Hospital
Beijing, China
West China Hospital, Sichuan University
Chendu, China
Qingdao Municipal Hospital
Qingdao, China
No. 202 Hospital of PLA （General Hospital of Northern Theater Command ）
Shenyang, China
Start Date
March 20, 2017
Primary Completion Date
October 22, 2017
Completion Date
October 30, 2017
Last Updated
July 16, 2020
NCT06732414
NCT05494346
NCT06061848
NCT06603935
NCT06151938
NCT05186025
Lead Sponsor
Beijing Tongren Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions